CannabisNewsBreaks Archive - CannabisNewsWire

FridayMar 24, 2023 12:37 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Efforts to Boost Commercial Prospects ‘Paying off in Spades’

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator developing and commercializing its patented DehydraTECH(TM) drug delivery technology. Lexaria is continuing and/or initiating discussions with several larger companies in Europe and North America regarding the licensed use of its technology for both consumer and pharmaceutical sectors. “The materialization of such partnerships hinges on a number of must-haves. Firstly, there must be a tangible product that draws larger companies. Secondly, The decision of whether or not to invest, and the scale of any investment, is based on how well the technologies that form the core of a company have been protected.…

ThursdayMar 23, 2023 1:47 pm

CannabisNewsBreaks – ECGI Holdings Inc. (ECGI) Inks Binding LOI to Acquire 8bit Cannabis Brand

ECGI Holdings (OTC: ECGI), D/B/A Elite Cannabis Group Incorporated, a Nevada -based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, has signed a binding letter of intent regarding the acquisition of key personnel, intellectual property, business operations and future business operations of Endless Consciousness Inc. ("EC"). A California corporation involved in the legal cannabis-product marketplace, EC recently launched a new brand, 8bit, which has experienced a rapidly expanding distribution footprint this year, with supplier relationships now reaching 20 dispensaries. Earlier this month, ECGI announced plans to acquire EC; the announcement observed that EC has serviced more than 250 stores and…

WednesdayMar 22, 2023 1:01 pm

CannabisNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) to Attend Investor Summit

IGC Pharma (NYSE American: IGC) (aka India Globalization Capital Inc.) today announced that its Chief Executive Officer Ram Mukunda and Principle Financial Officer Claudia Grimaldi will attend the Investor Summit on Wednesday, March 29, 2023. According to the update, Mukunda and Grimaldi will deliver a virtual company presentation at 11:30 a.m. ET and be available for virtual one-on-one meetings throughout the day. Interested investors should visit https://cnw.fm/HLeZs to register for the webinar and view the live presentation. To view the full press release, visit https://cnw.fm/JqoXj About IGC Pharma Inc. IGC Pharma is a clinical stage biotechnology company developing advanced cannabinoid-based…

MondayMar 20, 2023 2:49 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Represent the Future of Farming

Advanced Container Technologies’ (OTC: ACTX) innovative controlled environment farms – GrowPods – enable almost anyone to start growing leafy greens and certain vegetables 365 days a year in any environment. GrowPods are insulated, heated and cooled and can provide year-round, fresh produce for businesses, community groups, entrepreneurs, restaurants, grocery stores, and farmers. Even traditional farmers use GrowPods to supplement their income to cultivate high-profit herbs and produce year-round. ABC News in Denver reported that shipping container farming provides the opportunity to “grow anything, anywhere at any time,” including the upside of controlled environment farms located in urban areas to provide…

MondayMar 20, 2023 1:08 pm

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Rebrands, Including Changing Name to IGC Pharma, as Part of ‘Major Milestone’ Alignment

India Globalization Capital (NYSE American: IGC) (dba IGC Inc.) will begin operating under the name IGC Pharma Inc. (dba IGC), effective March 30, 2023; the name change is one aspect of the company’s rebranding strategy designed to better reflect its strategic focus and vision for the future. IGC’s common stock will trade on NYSE American exchange under the new name on March 31, 2023; the symbol will remain the same: IGC. According to the announcement, the change in name to IGC Pharma better represents the company’s focus as a developer of drug assets for treating diseases, including but not limited to…

FridayMar 17, 2023 1:32 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Moving Closer to Providing Alternative Hypertension Treatment with DehydraTECH(TM)-CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently reported additional findings from its most comprehensive clinical study yet, HYPER-H21-4. “The findings showed that DehydraTECH-CBD resulted in a statistically significant reduction in average baseline serum catestatin concentrations of 13.50 ng/mL to just 9.65 ng/mL after five weeks of dosing, representing a 28.5% drop. In addition, mean arterial pressure significantly dropped by 4.26 ± 1.26 mm/Hg following the five weeks of DehydraTECH-CBD dosing. No statistically significant reductions in catestatin concentrations were identified in the placebo group,” a recent article reads. “Given the growing demand for alternative anti-hypertensive…

MondayMar 13, 2023 2:50 pm

CannabisNewsBreaks – Prime Harvest Inc. Secures Reg A+ Qualification, Eyes New Heights of Opportunity

Prime Harvest, a technology focused, full-service cannabis company, recently announced that its Regulation A+ offering, which seeks to raise up to $42 million, had been qualified by the U.S. Securities and Exchange Commission (“SEC”). “The company has announced that gross proceeds from the equity raising will be destined towards the acquisition of licensed assets, the development of Prime Harvest’s direct-to-consumer application, expansion of the company’s state-wide delivery capabilities, as well as general corporate purposes,” a recent article reads. “Dating back to the company’s change in corporate strategy in 2019, a move which saw Prime Harvest transition from its origins as…

MondayMar 13, 2023 11:57 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Results Published

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has announced that results of its study have been published in the “International Journal of Molecular Sciences.” The study was designed to evaluate the anti-inflammatory effects of rare cannabinoids and their potential application for the treatment of skin conditions, including atopic dermatitis, psoriasis, pruritus and acne. The study is titled “Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signalling Pathway.” According to the announcement, study results demonstrate the therapeutic potential of rare cannabinoids in the…

FridayMar 10, 2023 1:21 pm

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Bringing Hope for Alzheimer’s Treatment

India Globalization Capital (NYSE American: IGC) is developing a cannabis-based investigational drug that is being tested for the first time ever on humans in an FDA-approved study. This is groundbreaking work that established its commitment as a pioneer in the treatment of Alzheimer’s disease, given there are no currently FDA-approved drugs to treat Alzheimer’s patients. “The company is developing its proprietary treatment, IGC-AD1, hoping to provide relief to the 55 million people worldwide struggling with agitation in dementia that results from Alzheimer’s. IGC is focused on revolutionizing the treatment of Alzheimer’s with its game-changing drug candidate. In phase 1 studies,…

FridayMar 10, 2023 11:05 am

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Issues Update on DLC Acquisition, Long-Term Strategic Plans

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, today provided an update to its recent announcement regarding the proposed acquisition of Diagnostic Lab Corporation Inc. of Englewood Cliffs, New Jersey (“DLC”), a diversified food and agriculture safety company, as well as the proposed recapitalization of the company. “We are providing this update to inform our many loyal shareholders that the company is making significant progress with respect to the DLC acquisition and securing additional capital, despite the challenging current macro-economic environment and its influence on the capital markets. Grapefruit’s management, staff and outside professionals continue to work together very…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks